Skip to main content

Advertisement

Log in

Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Between 14 and 85 % of patients report noticeable changes in cognitive function during chemotherapy (CTX). The purposes of this study were to determine which demographic, clinical, and symptom characteristics were associated with inter-individual variability in initial levels of attentional function as well as with changes in the trajectories of attentional function in a sample of oncology patients who received two cycles of CTX.

Methods

Oncology outpatients (n = 1329) were recruited from two comprehensive cancer centers, one veteran’s affairs hospital, and four community-based oncology programs. The Attentional Function Index (AFI) was used to assess perceived effectiveness in completing daily tasks that required working memory and attention. Hierarchical linear modeling (HLM) was used to evaluate for inter-individual variability in initial levels and in the trajectories of attentional function.

Results

Demographic, clinical, and symptom characteristics associated with inter-individual differences of attentional function at enrollment (i.e., intercept) were as follows: employment status, functional status, trait anxiety, depressive symptoms, sleep disturbance, evening fatigue, and morning energy. Gender was the only characteristic associated with inter-individual differences in the trajectories of attentional function. Morning fatigue was the only characteristic associated with both initial levels and the trajectories of attentional function.

Conclusions

Prior to their next dose of CTX, patients reported moderate levels of attentional function that persisted over two cycles of CTX. Many of the clinical and symptom characteristics associated with decrements in attentional function are amenable to interventions. Clinicians need to assess patients for changes in attentional function and associated characteristics and recommend evidence-based interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, LeFel J, Schagen SB, Ahles TA, Wefel JS, Vardy JL, Pancre V, Lange M, Castel H (2015) Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force symposium and update since 2012. J Pain Symptom Manag 50(6):830–841. doi:10.1016/j.jpainsymman.2015.06.019

    Article  Google Scholar 

  2. Hess LM, Insel KC (2007) Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum 34(5):981–994

    Article  PubMed  Google Scholar 

  3. Merriman JD, Von Ah D, Miaskowski C, Aouizerat BE (2013) Proposed mechanisms for cancer- and treatment-related cognitive changes. Semin Oncol Nurs 29(4):260–269. doi:10.1016/j.soncn.2013.08.006

    Article  PubMed  Google Scholar 

  4. Bender CM, Merriman JD (2014) Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead? Oncology (Williston Park) 28(9):806–808

    Google Scholar 

  5. Cimprich B (1992) Attentional fatigue following breast cancer surgery. Res Nurs Health 15(3):199–207

    Article  CAS  PubMed  Google Scholar 

  6. Merriman JD, Dodd M, Lee K, Paul SM, Cooper BA, Aouizerat BE, Swift PS, Wara W, Dunn L, Miaskowski C (2011) Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. Cancer Nurs 34(5):345–353. doi:10.1097/NCC.0b013e318202520a

    Article  PubMed  PubMed Central  Google Scholar 

  7. Merriman JD, Jansen C, Koetters T, West C, Dodd M, Lee K, Paul SM, Aouizerat BE, Cooper BA, Swift PS, Wara W, Miaskowski C (2010) Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy. Oncol Nurs Forum 37(4):423–432

    Article  PubMed  PubMed Central  Google Scholar 

  8. Merriman JD, Aouizerat BE, Cataldo JK, Dunn L, Cooper BA, West C, Paul SM, Baggott CR, Dhruva A, Kober K, Langford DJ, Leutwyler H, Ritchie CS, Abrams G, Dodd M, Elboim C, Hamolsky D, Melisko M, Miaskowski C (2014) Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer. Cytokine 65(2):192–201. doi:10.1016/j.cyto.2013.11.003

    Article  CAS  PubMed  Google Scholar 

  9. Johns SA, Von Ah D, Brown LF, Beck-Coon K, Talib TL, Alyea JM, Monahan PO, Tong Y, Wilhelm L, Giesler RB (2015) Randomized controlled pilot trial of mindfulness-based stress reduction for breast and colorectal cancer survivors: effects on cancer-related cognitive impairment. J Cancer Surviv. doi:10.1007/s11764-015-0494-3

    PubMed  Google Scholar 

  10. Myers JS, Wick JA, Klemp J (2015) Potential factors associated with perceived cognitive impairment in breast cancer survivors. Support Care Cancer 23(11):3219–3228. doi:10.1007/s00520-015-2708-7

    Article  PubMed  PubMed Central  Google Scholar 

  11. Miaskowski C, Cooper BA, Melisko M, Chen LM, Mastick J, West C, Paul SM, Dunn LB, Schmidt BL, Hammer M, Cartwright F, Wright F, Langford DJ, Lee K, Aouizerat BE (2014) Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy. Cancer 120(15):2371–2378. doi:10.1002/cncr.28699

    Article  PubMed  PubMed Central  Google Scholar 

  12. Karnofsky D, Abelmann WH, Craver LV, Burchenal JH (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656

    Article  Google Scholar 

  13. Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, Beer TM (2008) Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer 113(8):2205–2214. doi:10.1002/cncr.23856

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49(2):156–163. doi:10.1002/art.10993

    Article  PubMed  Google Scholar 

  15. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) AUDIT: the alcohol use disorders identification test: guidelines for use in primary care. World Health Organization, Geneva

    Google Scholar 

  16. Berks J, McCormick R (2008) Screening for alcohol misuse in elderly primary care patients: a systematic literature review. Int Psychogeriatr 20(6):1090–1103. doi:10.1017/S1041610208007497

    Article  PubMed  Google Scholar 

  17. Cimprich B, Visovatti M, Ronis DL (2011) The Attentional Function Index—a self-report cognitive measure. Psychooncology 20(2):194–202. doi:10.1002/pon.1729

    Article  PubMed  Google Scholar 

  18. Cimprich B, So H, Ronis DL, Trask C (2005) Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 14(1):70–78

    Article  PubMed  Google Scholar 

  19. Spielberger CG, Gorsuch RL, Suchene R, Vagg PR, Jacobs GA (1983) Manual for the State-Anxiety (Form Y): Self Evaluation Questionnaire. Consulting Psychologists Press, Palo Alto

    Google Scholar 

  20. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385–401

    Article  Google Scholar 

  21. Lee KA, Hicks G, Nino-Murcia G (1991) Validity and reliability of a scale to assess fatigue. Psychiatry Res 36(3):291–298

    Article  CAS  PubMed  Google Scholar 

  22. Fletcher BS, Paul SM, Dodd MJ, Schumacher K, West C, Cooper B, Lee K, Aouizerat B, Swift P, Wara W, Miaskowski CA (2008) Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol 26(4):599–605. doi:10.1200/JCO.2007.12.2838

    Article  PubMed  Google Scholar 

  23. Lee KA (1992) Self-reported sleep disturbances in employed women. Sleep 15(6):493–498

    CAS  PubMed  Google Scholar 

  24. Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17(2):197–210

    Article  CAS  PubMed  Google Scholar 

  25. IBM (2013) IBM SPSS Statistics for Windows, Version 22. IBM Corp, Armonk

    Google Scholar 

  26. Raudenbush SW, Bryk A (2002) Hierarchical linear models: applications and data analysis methods, 2nd edn. Sage Publications, Thousand Oaks

    Google Scholar 

  27. Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, West C, Aouizerat BE, Swift PS, Wara W (2008) Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy. J Pain Symptom Manag 35(6):632–643. doi:10.1016/j.jpainsymman.2007.07.007

    Article  Google Scholar 

  28. Osborne C, Berger LM, Magnuson K (2012) Family structure transitions and changes in maternal resources and well-being. Demography 49(1):23–47. doi:10.1007/s13524-011-0080-x

    Article  PubMed  PubMed Central  Google Scholar 

  29. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289. doi:10.3322/caac.21349

    Article  PubMed  Google Scholar 

  30. Merriman JD, Aouizerat BE, Langford DJ, Cooper BA, Baggott CR, Cataldo JK, Dhruva A, Dunn L, West C, Paul SM, Ritchie CS, Swift PS, Miaskowski C (2014) Preliminary evidence of an association between an interleukin 6 promoter polymorphism and self-reported attentional function in oncology patients and their family caregivers. Biol Res Nurs 16(2):152–159. doi:10.1177/1099800413479441

    Article  PubMed  Google Scholar 

  31. Hyde JS (2016) Sex and cognition: gender and cognitive functions. Curr Opin Neurobiol 38:53–56

    Article  CAS  PubMed  Google Scholar 

  32. Durdiakova J, Ostatnikova D, Celec P (2011) Testosterone and its metabolites—modulators of brain functions. Acta Neurobiol Exp (Wars) 71(4):434–454

    Google Scholar 

  33. Cimprich B (1999) Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs 22(3):185–194

    Article  CAS  PubMed  Google Scholar 

  34. Williams RA, Hagerty BM, Cimprich B, Therrien B, Bay E, Oe H (2000) Changes in directed attention and short-term memory in depression. J Psychiatr Res 34(3):227–238

    Article  CAS  PubMed  Google Scholar 

  35. Woollacott M, Shumway-Cook A (2002) Attention and the control of posture and gait: a review of an emerging area of research. Gait Posture 16(1):1–14

    Article  PubMed  Google Scholar 

  36. Bower JE, Ganz PA (2015) Symptoms: fatigue and cognitive dysfunction. Adv Exp Med Biol 862:53–75. doi:10.1007/978-3-319-16366-6_5

    Article  PubMed  Google Scholar 

  37. Visovatti MA, Reuter-Lorenz PA, Chang AE, Northouse L, Cimprich B (2016) Assessment of cognitive impairment and complaints in individuals with colorectal cancer. Oncol Nurs Forum 43(2):169–178. doi:10.1188/16.ONF.43-02AP

    Article  PubMed  Google Scholar 

  38. Dong ST, Costa DS, Butow PN, Lovell MR, Agar M, Velikova G, Teckle P, Tong A, Tebbutt NC, Clarke SJ, van der Hoek K, King MT, Fayers PM (2016) Symptom clusters in advanced cancer patients: an empirical comparison of statistical methods and the impact on quality of life. J Pain Symptom Manag 51(1):88–98. doi:10.1016/j.jpainsymman.2015.07.013

    Article  Google Scholar 

  39. Henneghan A (2016) Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review. Support Care Cancer 24(1):481–497. doi:10.1007/s00520-015-2927-y

    Article  PubMed  Google Scholar 

  40. Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470

    CAS  PubMed  Google Scholar 

  41. Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270–282

    Article  PubMed  Google Scholar 

  42. Piacentine LB, Miller JF, Haberlein S, Bloom AS (2016) Perceived cognitive changes with chemotherapy for breast cancer: a pilot study. Appl Nurs Res 29:9–11. doi:10.1016/j.apnr.2015.03.015

    Article  PubMed  Google Scholar 

  43. Falck RS, Davis JC, Liu-Ambrose T (2016) What is the association between sedentary behaviour and cognitive function? A systematic review. Br J Sports Med

  44. Montero-Odasso M, Bherer L, Studenski S, Gopaul K, Oteng-Amoako A, Woolmore-Goodwin S, Stoole P, Wells J, Doherty T, Zecevic AA, Galinsky D, Rylett RJ, Jutai J, Muir-Hunter S, Speechley M, Camicioli R (2015) Mobility and cognition in seniors. Report from the 2008 Institute of Aging (CIHR) Mobility and Cognition Workshop. Can Geriatr J 18(3):159–167. doi:10.5770/cgj.18.188

    Article  PubMed  PubMed Central  Google Scholar 

  45. Meneses-Echavez JF, Gonzalez-Jimenez E, Ramirez-Velez R (2015) Effects of supervised multimodal exercise interventions on cancer-related fatigue: systematic review and meta-analysis of randomized controlled trials. Biomed Res Int 2015:328636. doi:10.1155/2015/328636

    Article  PubMed  PubMed Central  Google Scholar 

  46. Tomlinson D, Diorio C, Beyene J, Sung L (2014) Effect of exercise on cancer-related fatigue: a meta-analysis. Am J Phys Med Rehabil 93(8):675–686. doi:10.1097/PHM.0000000000000083

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by the National Cancer Institute (NCI, CA134900). Dr. Miaskowski is supported by a grant from the American Cancer Society and NCI (CA168960). Ms. Shih was supported by grants from the Graduate Division of the University of California, San Francisco (UCSF) and from Associated Students of the UCSF School of Nursing to present her thesis findings at the Oncology Nursing Society’s 41st Annual Congress.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine Miaskowski.

Ethics declarations

The study was approved by the Institutional Review Board at each of the study sites. Written informed consent was obtained from all patients.

Conflict of interest

The authors declare that they have no competing interests.

Electronic supplementary material

Supplementary Table 1

(DOCX 22 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shih, J., Leutwyler, H., Ritchie, C. et al. Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy. Support Care Cancer 25, 783–793 (2017). https://doi.org/10.1007/s00520-016-3461-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3461-2

Keywords

Navigation